These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 210597)

  • 1. Immunization against swine influenza in the Yale University Community.
    Evans AS; Kraus G
    Yale J Biol Med; 1978; 51(2):165-76. PubMed ID: 210597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
    Boucher DW; Contreras G; Furesz J
    Can Med Assoc J; 1979 Apr; 120(7):799-802, 831. PubMed ID: 427686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza surveillance of Wisconsin (USA) population-detection of A/New Jersey by isolation and serologic monitoring and vaccine evaluation.
    Nelson DB; Inhorn SL
    Dev Biol Stand; 1977 Jun 1-3; 39():429-36. PubMed ID: 342315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against human and swine-like influenza A: serological response to two inactivated vaccines of different formulation.
    Cuneo-Crovari P; Giacometti G; Gasparini R; Fontana G
    Boll Ist Sieroter Milan; 1976; 55(5):371-8. PubMed ID: 1016590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
    Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swine influenza vaccine program in the community: acceptability, reactions and responses.
    Monto AS; Ross HW
    Am J Public Health; 1979 Mar; 69(3):233-7. PubMed ID: 217281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.
    Xie H; Li X; Gao J; Lin Z; Jing X; Plant E; Zoueva O; Eichelberger MC; Ye Z
    Clin Infect Dis; 2011 Dec; 53(12):1179-87. PubMed ID: 21976461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with monovalent and bivalent influenza vaccines in Canada 1976. Clinical evaluation of vaccines from four sources.
    Johnson SE; Pearson EW
    Dev Biol Stand; 1977 Jun 1-3; 39():267-72. PubMed ID: 342309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of hemagglutination-inhibition (HI) antibodies in gilts of breeding age by large dosages of human A/New Jersey/76 influenza vaccine.
    Woods GT; Mansfield ME
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):399-402. PubMed ID: 461965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.
    Treanor JJ; Campbell JD; Zangwill KM; Rowe T; Wolff M
    N Engl J Med; 2006 Mar; 354(13):1343-51. PubMed ID: 16571878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
    Boyer KM; Cherry JD; Noble GR
    Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal administration of bivalent and monovalent influenza vaccines.
    Brooks JH; Criep LH; Ruben FL
    Ann Allergy; 1977 Aug; 39(2):110-2. PubMed ID: 889154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.